This article contains massive Disclosure Day spoilers. It’s a single word with profound implications. On a night where the world feels like it is on the eve of WWIII, and the media breathlessly ...

While it’s not too surprising that the Euphoria series finale got metaphorical and bent reality a bit, it does merit a quick recap into what and and did not happen. Spoilers ahead for Euphoria season ...

‘Backrooms,’ by Kane Parsons, contains an intriguing monster that torments Clark (Chiwetel Ejiofor) and Dr. Mary Kline (Renate Reinsve), along with other mysteries—here’s what it all means. ByDani Di ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Credit: A24 Dark closets ...

After months of anticipation, Backrooms is finally playing in cinemas, taking horror fans and other viewers into the seemingly endless - and slightly unnerving - void of liminal spaces. The film, ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Be careful what you wish for. This idea, often explored in fiction, lies at the center of “Obsession,” Focus Features‘ new horror film from writer/director/editor Curry Barker. The movie follows Bear ...

Bill Dubiel is a veteran writer, editor, and college professor based in Buffalo, NY. Formerly of Screen Rant, you can usually find him in a late-night double feature, including the newest horror movie ...

More stories by Kevin P. After nearly 12 years, eight seasons, and 101 episodes, the mystical, magical love story of Claire and Jamie Fraser has come to an end. Or has it? Yes. But it's understandable ...

The final episode of Outlander dropped on the Starz app last night and now we finally know how Jamie (Sam Heughan) and Claire’s (Caitriona Balfe) epic love story ends. **Spoilers for Outlander Season ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...